PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1572555
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1572555
The Global Antimicrobial Hospital Textile Market was worth USD 8.3 billion in 2023 and will grow at 6.7% CAGR from 2024 to 2032, spurred by the rising awareness of hospital-acquired infections (HAIs) and the increasing frequency of infectious disease outbreaks. With HAIs posing serious health risks, hospitals are adopting antimicrobial textiles to reduce infection rates and improve patient safety. Moreover, outbreaks like COVID-19 have intensified the need for advanced protective measures, further boosting demand for antimicrobial textiles in healthcare settings. These textiles offer an added layer of defense, helping prevent cross-contamination and ensuring a safer environment for patients and staff.
The antimicrobial hospital textile industry is classified on the basis of material, usability, FDA class, application, hospital department, and region.
The cotton segment will reach USD 6.5 billion by 2032, owing to its widespread use, comfort, and breathability. Cotton is a preferred material in healthcare settings for items like bed linens, gowns, and scrubs, offering high durability and patient comfort. When treated with antimicrobial agents, cotton textiles provide effective protection against bacteria and pathogens, making them ideal for hospital use. Besides, the natural, hypoallergenic properties of cotton further enhance its appeal, driving its dominance in the market.
The reusable segment held USD 5.2 billion in 2023, driven by its cost-effectiveness and sustainability. Reusable antimicrobial textiles, such as gowns, bed linens, and surgical drapes, offer long-term durability and can withstand multiple wash cycles without losing their protective properties. This makes them a more economical option for healthcare facilities compared to disposable alternatives. Also, the growing focus on reducing medical waste and promoting eco-friendly practices is driving demand for reusable antimicrobial textiles, further strengthening their market position.
The U.S. antimicrobial hospital textile market share will reach USD 4.9 billion by 2032 due to its advanced healthcare infrastructure and stringent infection control standards. With a high number of hospitals and healthcare facilities, there is a significant demand for antimicrobial textiles to combat hospital-acquired infections and enhance patient safety. The U.S. also leads in adopting innovative healthcare solutions and regulatory standards, driving the growth of antimicrobial textiles. Additionally, the country's focus on infection prevention and control makes it a key contributor to the market's expansion.